Skip to main content

Table 2 Multiplicity of infection and proportion of polyclonal infections according to previous IPTi with SP

From: Multiplicity of Plasmodium falciparum infection following intermittent preventive treatment in infants

Stratum

No.

IPTI : placebo

mean MOI (median, range)

P

Proportion of polyclonal infections (%)

P

  

Previous IPTi

Previous Placebo

 

Previous IPTi

Previous Placebo

 

All

191 : 198

2.25 (2, 1-5)

2.33 (2, 1-6)

0.55

69.6

69.7

0.99

All microscopically positive

135 : 142

2.42 (2, 1-5)

2.38 (2, 1-6)

0.78

74.8

72.5

0.67

Afigya Sekyere

85 : 88

2.29 (2, 1-5)

2.31 (2, 1-6)

0.92

69.4

71.6

0.75

Tamale, all

106 : 110

2.22 (2, 1-5)

2.35 (2, 1-5)

0.49

69.8

68.2

0.80

Tamale, microscopically positive

50 : 54

2.64 (2.5, 1-5)

2.50 (2, 1-5)

0.59

84.0

74.1

0.22

Tamale, submicroscopic

56 : 56

1.84 (2, 1-5)

2.20 (2, 1-5)

0.17

57.1

62.5

0.56

  1. P, comparisons by Mann-Whitney U test or χ2 test